Literature DB >> 2301590

Attenuation of hypermetabolism in the remnant kidney by dietary phosphate restriction in the rat.

J I Shapiro1, D C Harris, R W Schrier, L Chan.   

Abstract

In vivo energy metabolism in remnant and normal kidney nephrons and the effect of dietary phosphate restriction on energy metabolism were studied. Tissue concentrations of ATP did not differ between remnant and normal kidneys; however, the tissue concentration of inorganic phosphate (Pi) was higher in remnant kidneys (1.17 +/- 0.10 vs. 0.82 +/- 0.09 mumol/g, P less than 0.05) as assessed by 31P-nuclear magnetic resonance (NMR). Intracellular pH was also higher in remnant kidneys (7.48 +/- 0.04 vs. 7.20 +/- 0.05, P less than 0.01), as was oxygen consumption (QO2) when normalized for rate of net tubular sodium reabsorption (Tna; 0.032 +/- 0.005 vs. 0.018 +/- 0.002 mumol.min-1.g-1, P less than 0.01). Compared with glycine supplemented controls, dietary phosphate restriction induced by the phosphate binder diaminodihydroacetoacetate, a maneuver which independently of protein restriction has been shown to ameliorate the progression of chronic renal failure, resulted in no major change in tissue levels of ATP, intracellular pH, or TNa+ but decreased Pi (0.62 +/- 0.07 vs. 1.40 +/- 0.11 mumol/g, P less than 0.01) and QO2 (4.0 +/- 0.4 vs. 7.7 +/- 1.0 mumol.min-1.g-1, P less than 0.01) in remnant kidneys. For the amount of sodium reabsorption performed, remnant kidneys are hypermetabolic, and this hypermetabolism is attenuated by dietary phosphate restriction. These data suggest that hypermetabolism may be involved in the tubulointerstitial mechanisms operant in the progression of chronic renal failure that occurs in the rat remnant kidney, and that attenuation of this abnormality may be the mechanism by which dietary phosphate restriction ameliorates this process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2301590     DOI: 10.1152/ajprenal.1990.258.1.F183

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure.

Authors:  Steven T Haller; David J Kennedy; Amjad Shidyak; George V Budny; Deepak Malhotra; Olga V Fedorova; Joseph I Shapiro; Alexei Y Bagrov
Journal:  Am J Hypertens       Date:  2012-03-01       Impact factor: 2.689

Review 2.  The physiological and clinical importance of sodium potassium ATPase in cardiovascular diseases.

Authors:  Yanling Yan; Joseph I Shapiro
Journal:  Curr Opin Pharmacol       Date:  2016-02-15       Impact factor: 5.547

3.  Mitochondrial impairment in the five-sixth nephrectomy model of chronic renal failure: proteomic approach.

Authors:  Larisa V Fedorova; Anita Tamirisa; David J Kennedy; Steven T Haller; Georgy Budnyy; Joseph I Shapiro; Deepak Malhotra
Journal:  BMC Nephrol       Date:  2013-10-04       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.